ly 274614 has been researched along with 2-amino-4-oxo-5-chloropentanoate in 1 studies
| Studies (ly 274614) | Trials (ly 274614) | Recent Studies (post-2010) (ly 274614) | Studies (2-amino-4-oxo-5-chloropentanoate) | Trials (2-amino-4-oxo-5-chloropentanoate) | Recent Studies (post-2010) (2-amino-4-oxo-5-chloropentanoate) |
|---|---|---|---|---|---|
| 96 | 0 | 15 | 8 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, JS; Zang, MW | 1 |
1 review(s) available for ly 274614 and 2-amino-4-oxo-5-chloropentanoate
| Article | Year |
|---|---|
[Blockade of opioid tolerance and dependence by NMDA receptor antagonist].
Topics: Animals; Dizocilpine Maleate; Humans; Isoquinolines; Levulinic Acids; Opioid-Related Disorders; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid | 1999 |